ArticleProceedings of the National Academy of Sciences of the United States of America2007

HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription.

Christine Goffinet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.